|
|
|
|
|
HONG KONG, Dec 1, 2014 - (ACN Newswire) - China Pioneer Pharma Holdings Limited announced recently that Singapore's Health Sciences Authority(HSA) has approved the launch of JUTURNA-vq PTA Balloon Dilatation Catheter in Singapore on 24th November, which is the medical device produced by QualiMed Innovative MedizinprodukteGmbh (QualiMed). The Company is the exclusive distributor of JUTURNA-vq PTA Balloon Dilatation Catheter This medical device product has previously been approved for sale throughout Hong Kong, Thailand and Vietnam. China Pioneer Pharma owns about 24.4% shares of Q3 Medical Devices Limited, which is the holding company of QualiMed. The Company is also the exclusive distributor of QualiMed's medical products for vascular disease treatment in mainland China and throughout Southeast Asia.
JUTURNA-vq PTA Balloon Dilatation Catheter is a kind of medical devices for endovascular treatment, make tiny channel of a few millimeters in diameter in the vessel and skin under the condition of exposing lesions without the surgery and treat them with minimal trauma under the guidance of imaging equipment. The JUTURNA-vq PTA Balloon Catheter is indicated for Percutaneous Transluminal Angioplasty (PTA) in the peripheral vasculature, including iliac, femoral, ilio-femoral, popliteal, infra-popliteal and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
Mr. LI Xinzhou, Chairman, Executive Director and Chief Executive Officer of China Pioneer Pharma said: "Compared with the ordinary balloon dilatation catheter, JUTURNA-vq PTA Balloon Dilatation Catheter could facilitate the operation of the doctors with the help of its outer-lateral and tip design is highly adaptive, which enables it to advance into the patients vascular and through lumen stenosis easily and smoothly with minimal trauma of the patients. This medical device will improve the Medical and health care industry in Singapore remarkably."
Topic: Press release summary
Source: China Pioneer Pharma Holdings Limited
Sectors: Daily Finance, Daily News, BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
